Bristol Myers Squibb Plans 10-Year Strategy to Expand Access to Medications
The company is collaborating with the Access to Oncology Medicines Coalition to expand patient access to immuno-oncology therapy Opdivo. Bristol Myers Squibb (BMS) announced on May 22, 2024 that it is creating a 10-year plan—ASPIRE (Accessibility, …